Princess Margaret Cancer Centre

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Active, not recruiting	Phase 2	2026-07-24		NCT05926765
Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation	Locally Advanced, Unresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation	Recruiting	Phase 1 / Phase 2	2026-05-11		NCT06501625

Clinical trials